This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Clarient, Inc. In Connection With The Proposed Acquisition Of The Company By GE Healthcare

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Clarient, Inc. (“Clarient” or the “Company”) (NASDAQ:CLRT) related to the Company’s agreement to be acquired by GE Healthcare, a unit of General Electric Company (“GE”). The proposed transaction is valued at approximately $580 million.

Under the terms of the definitive agreement entered into by the parties, a subsidiary of GE will commence a tender offer to purchase all outstanding common and preferred shares of Clarient, for $5.00 in cash per common share and $20.00 in cash per preferred share. Clarient’s board of directors has unanimously approved the proposed transaction. The transaction is expected to be completed by late 2010 or early 2011. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the proposed transaction by Clarient’s board of directors.

If you are a shareholder of Clarient, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs